Vaccine maker got $1 billion from taxpayers. Now it's boosting drug prices

Monday, September 14, 2020 - 18:30 in Mathematics & Economics

AstraZeneca, which received U.S. funds to develop a COVID-19 vaccine, raised prices despite promises by President Trump to keep drug costs in check.

Read the whole article on LA Times - Health

More from LA Times - Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net